請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73880
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘建源(Chien-Yuan Pan) | |
dc.contributor.author | You-Hao He | en |
dc.contributor.author | 何祐豪 | zh_TW |
dc.date.accessioned | 2021-06-17T08:12:40Z | - |
dc.date.available | 2019-08-20 | |
dc.date.copyright | 2019-08-20 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-15 | |
dc.identifier.citation | Acquier, A.B., Mori Sequeiros Garcia, M., Gorostizaga, A.B., Paz, C., and Mendez, C.F. (2013). Reactive oxygen species mediate dopamine-induced signaling in renal proximal tubule cells. FEBS Lett 587, 3254-3260.
Alex, K.D., and Pehek, E.A. (2007). Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113, 296-320. Allan, S.M., Tyrrell, P.J., and Rothwell, N.J. (2005). Interleukin-1 and neuronal injury. Nat Rev Immunol 5, 629-640. Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V.M., Trojanowski, J.Q., and Iwatsubo, T. (1998). Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152, 879-884. Bandman, O., Coleman, R.T., Loring, J.F., Seilhamer, J.J., and Cocks, B.G. (2002). Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann N Y Acad Sci 975, 77-90. Basu, S., and Dasgupta, P.S. (2000). Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 102, 113-124. Berg, D., Postuma, R.B., Adler, C.H., Bloem, B.R., Chan, P., Dubois, B., Gasser, T., Goetz, C.G., Halliday, G., Joseph, L., et al. (2015). MDS research criteria for prodromal Parkinson's disease. Mov Disord 30, 1600-1611. Bergsbaken, T., Fink, S.L., and Cookson, B.T. (2009). Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7, 99-109. Boxer, M.B., Shen, M., Auld, D.S., Wells, J.A., and Thomas, C.J. (2010). A small molecule inhibitor of Caspase 1. In Probe Reports from the NIH Molecular Libraries Program (Bethesda (MD)). Bromberg-Martin, E.S., Matsumoto, M., and Hikosaka, O. (2010). Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815-834. Burbulla, L.F., Song, P., Mazzulli, J.R., Zampese, E., Wong, Y.C., Jeon, S., Santos, D.P., Blanz, J., Obermaier, C.D., Strojny, C., et al. (2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. Science 357, 1255-1261. Chen, J., Rusnak, M., Lombroso, P.J., and Sidhu, A. (2009). Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. Eur J Neurosci 29, 287-306. Chung, J., Chang, S., Kim, Y., and Shin, H. (2000). Zinc increases the excitability of dopaminergic neurons in rat substantia nigra. Neurosci Lett 286, 183-186. de Lau, L.M., and Breteler, M.M. (2006). Epidemiology of Parkinson's disease. Lancet Neurol 5, 525-535. Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agid, Y., Jenner, P., and Marsden, C.D. (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52, 1830-1836. Dinarello, C.A. (2005). Blocking IL-1 in systemic inflammation. J Exp Med 201, 1355-1359. Ebrahimi, T., Rust, M., Kaiser, S.N., Slowik, A., Beyer, C., Koczulla, A.R., Schulz, J.B., Habib, P., and Bach, J.P. (2018). alpha1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid beta1-42-stimulated murine astrocytes. J Neuroinflammation 15, 282. Eide, D.J. (2004). The SLC39 family of metal ion transporters. Pflugers Arch 447, 796-800. Eisele, Y.S., Monteiro, C., Fearns, C., Encalada, S.E., Wiseman, R.L., Powers, E.T., and Kelly, J.W. (2015). Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov 14, 759-780. Fan, Y., Du, L., Fu, Q., Zhou, Z., Zhang, J., Li, G., and Wu, J. (2018). Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice. Front Cell Neurosci 12, 426. Fann, D.Y., Lee, S.Y., Manzanero, S., Tang, S.C., Gelderblom, M., Chunduri, P., Bernreuther, C., Glatzel, M., Cheng, Y.L., Thundyil, J., et al. (2013). Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 4, e790. Fann, D.Y., Lim, Y.A., Cheng, Y.L., Lok, K.Z., Chunduri, P., Baik, S.H., Drummond, G.R., Dheen, S.T., Sobey, C.G., Jo, D.G., et al. (2018). Evidence that NF-kappaB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke. Mol Neurobiol 55, 1082-1096. Fantuzzi, G., and Dinarello, C.A. (1999). Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 19, 1-11. Fettelschoss, A., Kistowska, M., LeibundGut-Landmann, S., Beer, H.D., Johansen, P., Senti, G., Contassot, E., Bachmann, M.F., French, L.E., Oxenius, A., et al. (2011). Inflammasome activation and IL-1beta target IL-1alpha for secretion as opposed to surface expression. Proc Natl Acad Sci U S A 108, 18055-18060. Flores, J., Noel, A., Foveau, B., Lynham, J., Lecrux, C., and LeBlanc, A.C. (2018). Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model. Nat Commun 9, 3916. Frederickson, C.J., Suh, S.W., Silva, D., Frederickson, C.J., and Thompson, R.B. (2000). Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130, 1471S-1483S. Fricker, M., Tolkovsky, A.M., Borutaite, V., Coleman, M., and Brown, G.C. (2018). Neuronal Cell Death. Physiol Rev 98, 813-880. Gabay, C., Lamacchia, C., and Palmer, G. (2010). IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6, 232-241. Goni, F., Marta-Ariza, M., Peyser, D., Herline, K., and Wisniewski, T. (2017). Production of Monoclonal Antibodies to Pathologic beta-sheet Oligomeric Conformers in Neurodegenerative Diseases. Sci Rep 7, 9881. Gorman, A.M. (2008). Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med 12, 2263-2280. Griffin, W.S., Liu, L., Li, Y., Mrak, R.E., and Barger, S.W. (2006). Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation 3, 5. Gross, O., Yazdi, A.S., Thomas, C.J., Masin, M., Heinz, L.X., Guarda, G., Quadroni, M., Drexler, S.K., and Tschopp, J. (2012). Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36, 388-400. Guo, H., Callaway, J.B., and Ting, J.P. (2015). Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 21, 677-687. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., and Golenbock, D.T. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9, 857-865. Hartmann, A. (2004). Postmortem studies in Parkinson's disease. Dialogues Clin Neurosci 6, 281-293. Hayashi, Y., Jikihara, I., Yagi, T., Fukumura, M., Ohashi, Y., Ohta, Y., Takagi, H., and Maeda, M. (2001). Immunohistochemical investigation of caspase-1 and effect of caspase-1 inhibitor in delayed neuronal death after transient cerebral ischemia. Brain Res 893, 113-120. Heneka, M.T., Kummer, M.P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.C., et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678. Hnasko, T.S., Hjelmstad, G.O., Fields, H.L., and Edwards, R.H. (2012). Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J Neurosci 32, 15076-15085. Holzberg, D., Knight, C.G., Dittrich-Breiholz, O., Schneider, H., Dorrie, A., Hoffmann, E., Resch, K., and Kracht, M. (2003). Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J Biol Chem 278, 40213-40223. Huang, X., Atwood, C.S., Moir, R.D., Hartshorn, M.A., Vonsattel, J.P., Tanzi, R.E., and Bush, A.I. (1997). Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J Biol Chem 272, 26464-26470. Huising, M.O., Stet, R.J., Savelkoul, H.F., and Verburg-van Kemenade, B.M. (2004). The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28, 395-413. Hung, H.H., Kao, L.S., Liu, P.S., Huang, C.C., Yang, D.M., and Pan, C.Y. (2017). Dopamine elevates intracellular zinc concentration in cultured rat embryonic cortical neurons through the cAMP-nitric oxide signaling cascade. Mol Cell Neurosci 82, 35-45. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B., and Hirsch, E.C. (1999). FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19, 3440-3447. Ikemoto, S. (2007). Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56, 27-78. Iori, V., Frigerio, F., and Vezzani, A. (2016). Modulation of neuronal excitability by immune mediators in epilepsy. Curr Opin Pharmacol 26, 118-123. Jenner, P. (2003). Oxidative stress in Parkinson's disease. Ann Neurol 53 Suppl 3, S26-36; discussion S36-28. Jimenez-Jimenez, F.J., Fernandez-Calle, P., Martinez-Vanaclocha, M., Herrero, E., Molina, J.A., Vazquez, A., and Codoceo, R. (1992). Serum levels of zinc and copper in patients with Parkinson's disease. J Neurol Sci 112, 30-33. Junn, E., and Mouradian, M.M. (2001). Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78, 374-383. Kacprzak, V., Patel, N.A., Riley, E., Yu, L., Yeh, J.J., and Zhdanova, I.V. (2017). Dopaminergic control of anxiety in young and aged zebrafish. Pharmacol Biochem Behav 157, 1-8. Kahlig, K.M., and Galli, A. (2003). Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol 479, 153-158. Kaushal, V., Dye, R., Pakavathkumar, P., Foveau, B., Flores, J., Hyman, B., Ghetti, B., Koller, B.H., and LeBlanc, A.C. (2015). Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ 22, 1676-1686. Keller, M., Ruegg, A., Werner, S., and Beer, H.D. (2008). Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831. Kim, B., Lee, Y., Kim, E., Kwak, A., Ryoo, S., Bae, S.H., Azam, T., Kim, S., and Dinarello, C.A. (2013). The Interleukin-1alpha Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines. Front Immunol 4, 391. Kim, T.D., Paik, S.R., Yang, C.H., and Kim, J. (2000). Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 9, 2489-2496. Kitazawa, M., Oddo, S., Yamasaki, T.R., Green, K.N., and LaFerla, F.M. (2005). Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25, 8843-8853. Kozlowski, H., Luczkowski, M., Remelli, M., and Valensin, D. (2012). Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coordination Chemistry Reviews 256, 2129-2141. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S., and Flavell, R.A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003. Laity, J.H., Lee, B.M., and Wright, P.E. (2001). Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol 11, 39-46. Lammel, S., Lim, B.K., and Malenka, R.C. (2014). Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76 Pt B, 351-359. Lee, J.Y., Cole, T.B., Palmiter, R.D., Suh, S.W., and Koh, J.Y. (2002). Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A 99, 7705-7710. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et al. (1995). Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80, 401-411. Lin, A.M., Wu, L.Y., Hung, K.C., Huang, H.J., Lei, Y.P., Lu, W.C., and Hwang, L.S. (2012). Neuroprotective effects of longan ( Dimocarpus longan Lour.) flower water extract on MPP+-induced neurotoxicity in rat brain. J Agric Food Chem 60, 9188-9194. Lin, M.T., and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., and Markesbery, W.R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52. Lull, M.E., and Block, M.L. (2010). Microglial activation and chronic neurodegeneration. Neurotherapeutics 7, 354-365. Malik, A., and Kanneganti, T.D. (2018). Function and regulation of IL-1alpha in inflammatory diseases and cancer. Immunol Rev 281, 124-137. Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., and Xue, Z. (2017). The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats. Neurochem Res 42, 1104-1115. Margolis, E.B., Toy, B., Himmels, P., Morales, M., and Fields, H.L. (2012). Identification of rat ventral tegmental area GABAergic neurons. PLoS One 7, e42365. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10, 417-426. Martorana, A., and Koch, G. (2014). 'Is dopamine involved in Alzheimer's disease?'. Front Aging Neurosci 6, 252. McGeer, P.L., and McGeer, E.G. (2001). Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22, 799-809. McGeer, P.L., and McGeer, E.G. (2013). The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126, 479-497. McKenzie, B.A., Mamik, M.K., Saito, L.B., Boghozian, R., Monaco, M.C., Major, E.O., Lu, J.Q., Branton, W.G., and Power, C. (2018). Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A 115, E6065-E6074. Mor, D.E., Tsika, E., Mazzulli, J.R., Gould, N.S., Kim, H., Daniels, M.J., Doshi, S., Gupta, P., Grossman, J.L., Tan, V.X., et al. (2017). Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration. Nat Neurosci 20, 1560-1568. Palmiter, R.D., and Huang, L. (2004). Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch 447, 744-751. Petrilli, M.A., Kranz, T.M., Kleinhaus, K., Joe, P., Getz, M., Johnson, P., Chao, M.V., and Malaspina, D. (2017). The Emerging Role for Zinc in Depression and Psychosis. Front Pharmacol 8, 414. Pozzi, D., Menna, E., Canzi, A., Desiato, G., Mantovani, C., and Matteoli, M. (2018). The Communication Between the Immune and Nervous Systems: The Role of IL-1beta in Synaptopathies. Front Mol Neurosci 11, 111. Rana, M., and Sharma, A.K. (2019). Cu and Zn interactions with Abeta peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Abeta oligomers. Metallomics 11, 64-84. Riek, R., and Eisenberg, D.S. (2016). The activities of amyloids from a structural perspective. Nature 539, 227-235. Rink, L., and Gabriel, P. (2000). Zinc and the immune system. Proc Nutr Soc 59, 541-552. Ritz, B.R., Manthripragada, A.D., Costello, S., Lincoln, S.J., Farrer, M.J., Cockburn, M., and Bronstein, J. (2009). Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect 117, 964-969. Rosenberg, P.A. (1988). Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8, 2887-2894. Salazar, G., Huang, J., Feresin, R.G., Zhao, Y., and Griendling, K.K. (2017). Zinc regulates Nox1 expression through a NF-kappaB and mitochondrial ROS dependent mechanism to induce senescence of vascular smooth muscle cells. Free Radic Biol Med 108, 225-235. Sarkar, C., Basu, B., Chakroborty, D., Dasgupta, P.S., and Basu, S. (2010). The immunoregulatory role of dopamine: an update. Brain Behav Immun 24, 525-528. Schielke, G.P., Yang, G.Y., Shivers, B.D., and Betz, A.L. (1998). Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18, 180-185. Segura-Aguilar, J., Paris, I., Munoz, P., Ferrari, E., Zecca, L., and Zucca, F.A. (2014). Protective and toxic roles of dopamine in Parkinson's disease. J Neurochem 129, 898-915. Sensi, S.L., Paoletti, P., Bush, A.I., and Sekler, I. (2009). Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 10, 780-791. Sheng, J.G., Bora, S.H., Xu, G., Borchelt, D.R., Price, D.L., and Koliatsos, V.E. (2003). Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14, 133-145. Shingai, Y., Tateno, A., Arakawa, R., Sakayori, T., Kim, W., Suzuki, H., and Okubo, Y. (2014). Age-related decline in dopamine transporter in human brain using PET with a new radioligand [(1)(8)F]FE-PE2I. Ann Nucl Med 28, 220-226. Simi, A., Tsakiri, N., Wang, P., and Rothwell, N.J. (2007). Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35, 1122-1126. Smart, T.G., Hosie, A.M., and Miller, P.S. (2004). Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10, 432-442. Song, L., Pei, L., Yao, S., Wu, Y., and Shang, Y. (2017). NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies. Front Cell Neurosci 11, 63. Spina, M.B., and Cohen, G. (1989). Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci U S A 86, 1398-1400. Strijbos, P.J., and Rothwell, N.J. (1995). Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 15, 3468-3474. Takeda, A., and Tamano, H. (2009). Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev 62, 33-44. Tapiero, H., and Tew, K.D. (2003). Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 57, 399-411. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774. Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Ogden, K.K., Hansen, K.B., Yuan, H., Myers, S.J., and Dingledine, R. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62, 405-496. Vallee, B.L., and Auld, D.S. (1993). Cocatalytic zinc motifs in enzyme catalysis. Proc Natl Acad Sci U S A 90, 2715-2718. Viola, K.L., and Klein, W.L. (2015). Amyloid beta oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129, 183-206. von Herrmann, K.M., Salas, L.A., Martinez, E.M., Young, A.L., Howard, J.M., Feldman, M.S., Christensen, B.C., Wilkins, O.M., Lee, S.L., Hickey, W.F., et al. (2018). NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease. NPJ Parkinsons Dis 4, 24. Wang, J., Tan, L., Wang, H.F., Tan, C.C., Meng, X.F., Wang, C., Tang, S.W., and Yu, J.T. (2015). Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. J Alzheimers Dis 44, 385-396. Wannamaker, W., Davies, R., Namchuk, M., Pollard, J., Ford, P., Ku, G., Decker, C., Charifson, P., Weber, P., Germann, U.A., et al. (2007). (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoy l)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 321, 509-516. Weber, A., Wasiliew, P., and Kracht, M. (2010). Interleukin-1 (IL-1) pathway. Sci Signal 3, cm1. Wise, R.A., and Rompre, P.P. (1989). Brain dopamine and reward. Annu Rev Psychol 40, 191-225. Wong, R., Lenart, N., Hill, L., Toms, L., Coutts, G., Martinecz, B., Csaszar, E., Nyiri, G., Papaemmanouil, A., Waisman, A., et al. (2019). Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons. Brain Behav Immun 76, 126-138. Zeevalk, G.D., Bernard, L.P., and Nicklas, W.J. (1998). Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70, 1421-1430. Zhang, N., Zhang, X., Liu, X., Wang, H., Xue, J., Yu, J., Kang, N., and Wang, X. (2014). Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice. Mediators Inflamm 2014, 370530. Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., and Barzilai, A. (1994). Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci Lett 170, 136-140. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73880 | - |
dc.description.abstract | 帕金森氏症(Parkinson’s disease, PD)是非常普遍的神經退化性疾病僅次於阿茲海默症,研究顯示在全世界高於60 歲的人口中有2%的人會罹患PD。而PD的致病機制主要是因為腦部黑質的多巴胺能神經細胞死亡,而造成神經細胞死亡原因很多如氧化壓力、粒線體功能失常、DNA損傷及小膠質細胞的活化等機制。在我們過去的研究中證實了多巴胺會引發細胞自噬及胞質內鋅離子濃度上升最終導致神經細胞死亡。另外過去實驗室透過次世代定序分析發現多巴胺會造成IL-1β及許多與神經發炎反應相關的基因表現量上升,而這些基因都涉及細胞焦亡的途徑但確切機制尚未清楚。為了探究在細胞死亡的過程中鋅離子對於神經發炎反應之間的影響,因此我們使用初代細胞培養的大鼠神經細胞處理多巴胺250 µM 及 氯化鋅 200 µM 18小時引發細胞死亡並測試抑制神經發炎反應對於抵抗細胞死亡的效果。除此之外細胞預處理發炎反應的抑制劑MCC950及VX-765 都可以減少氯化鋅所造成的細胞死亡。從PCR實驗數據中我們發現神經細胞處理多巴胺及氯化鋅後神經發炎相關的基因 IL-1β表現確實增加。因此根據我們的實驗結果可以說明發炎反應參與了鋅離子濃度上升引發的細胞死亡,而此類型的細胞死亡應該是細胞焦亡。我們的發現提供了一個新的關於多巴胺所造成的細胞死亡機制,且在未來可以發展成為神經退化性疾病的療法。 | zh_TW |
dc.description.abstract | Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting about 2% of the world’s population over 60 years old. The pathogenic mechanism of PD is the loss of dopaminergic neurons in the substantia nigra (SN), which may be caused by the oxidative stress, mitochondrial dysfunction, DNA damage, microglial cell activation etc. Our previous work has verified that dopamine (DA) can induce autophagy and elevate intracellular Zn2+ concentration resulting in the death of cultured neurons, however, it is not clear the roles Zn2+ plays in these processes. Our preliminary results using NGS analysis shows that DA treatment increase the expression of IL-1β and several neuroinflammation-related genes suggesting the involvement of pyroptosis but not well-characterized yet. It is not clear how Zn2+-neuroinflammation pathway causes the cell death; therefore, we further investigated the roles of inflammasome plays in primary cultured rat embryonic cortical neurons after DA or Zn2+ treatment. We treated the neurons with DA (250 µM) and /or Zn2+ (200 µM) for 18 hrs to induce neuron death and tested the effects of inhibitor against the NLRP3-inflammasome pathway. MCC950, an NLRP3-inflammasome inhibitor, reduced ZnCl2-induced neuron death. VX-765 (caspase 1 inhibitor) can reverse the ZnCl2-induced neuron death. Therefore, these results suggest the involvement of neuroinflammation in Zn2+-induced cell death, which may be mediated by the pyroptosis pathway. The PCR results show that the expression levels of IL-1β increased under the DA and Zn2+ treatment. Our findings provide a new mechanism involved in DA-induced neuron death from which we can develop a new therapeutic strategy to alleviate the neurodegeneration. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T08:12:40Z (GMT). No. of bitstreams: 1 ntu-108-R06b21024-1.pdf: 1278536 bytes, checksum: ca7fd89835398a437e4c7f6c55b08d08 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | Abstract 2
摘要 4 1. Introduction 5 1.1. The Pathogenic Mechanisms of the Neurodegenerative Diseases 5 1.2. Dopamine and Oxidation Stress 6 1.3. Zinc induces neuron death 7 1.4. The Dopaminergic system 10 1.5. The mechanism of neuroinflammation 11 1.6. The IL-1 family 12 1.7. Cell death 14 1.8. NLRP3-Caspase 1pathway 15 1.9. MCC950 and VX-765 16 1.10. Aims 17 2. Material and methods 19 2.1. Chemicals 19 2.2. Cell culture 19 2.3. mRNA expression 21 2.4. MTT Assay 22 2.5. TUNEL Assay 22 2.6. Drug treatment 23 2.7. Data analysis 23 3. Results 24 3.1. Dopamine induces PC12 cell death 24 3.2. DA treatment causes neuronal cell death 24 3.3. Zn2+-induced neuron death is dose-dependent 25 3.4. IL-1β pretreatment protects the neuron from DA treatment 25 3.5. IL-1β pretreatment inhibits the cell death induced by ZnCl2 treatment 26 3.6. MCC950 reverses the Zn2+-induced neuron death 26 3.7. VX-765 suppresses Zn2+-induced neuron death 27 3.8. Zn2+ treatment increases the IL-1β gene expression 28 4. Discussion 29 5. References 32 6. Table and Figures 50 | |
dc.language.iso | en | |
dc.title | 探討NLRP3-Caspase 1 機制在鋅離子引發大鼠初代培養神經元死亡的角色 | zh_TW |
dc.title | The Roles of NLRP3-Caspase 1 Pathway in Zn2+-induced Cell Death of Primary-Cultured Rat Embryonic Cortical Neuron | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 廖永豐(Yung-Feng Liao),梁有志(Yu-Chih Liang),李怡萱(Yi-Hsuan Lee) | |
dc.subject.keyword | 神經退化性疾病,多巴胺能神經細胞,鋅離子,發炎反應,基因表現, | zh_TW |
dc.subject.keyword | Neurodegenerative disease,dopaminergic neurons,Zinc ion,Neuroinflammation,Gene expression, | en |
dc.relation.page | 62 | |
dc.identifier.doi | 10.6342/NTU201903490 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-15 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生命科學系 | zh_TW |
顯示於系所單位: | 生命科學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 1.25 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。